Keywords: ucb, keppra, effective, infant, seizure, study, belgian

UCB's Keppra effective in infant seizure study

Article | 30 April 2007

Print This

Belgian pharmaceutical group UCB says that, in a Phase III study, its oral antiepileptic Keppra (levetiracetam) reduced the frequency of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in